Direct-to-Biology, a powerful approach to accelerate hit finding: Concept and application to drug discovery programs

In the first of our Drug Discovery webinar series, we discussed Direct-to-Biology (D2B) and its potential to accelerate hit finding. The series is hosted by One Nucleus.

Direct-to-Biology (D2B) has emerged as a powerful method to find hit compounds and build Structure Activity Relationships (SAR) for drug discovery programs. During this webinar, we covered the concept of D2B and how and when it can be applied to drug-discovery programs